GKOS GLAUKOS CORP
2026Q1 · CUSIP 377322102 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
333
Δ holders QoQ
+1
Breadth percentile
Top 58%
Whale holders
173
Δ whales
+2
Inst. holding value
$6.2B
New positions
50
Closed positions
49
Price momentum (1Q)
+33.3%
Put / Call
5/6
Breadth history (34 quarters)
Past Lit Events & Aftermath 8 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2024Q3 | Top 9% | -8.1% | -29.0% |
| 2024Q2 | Top 7% | +8.8% | +26.0% |
| 2023Q3 | Top 14% | +42.3% | +68.8% |
| 2023Q2 | Top 13% | -11.0% | +29.6% |
| 2022Q3 | Top 4% | +2.9% | +17.1% |
| 2020Q1 | Top 12% | +17.4% | +86.3% |
| 2019Q1 | Top 9% | -6.4% | -6.7% |
| 2018Q3 | Top 10% | +10.8% | +8.5% |
Options Sentiment
Put holders
5
QoQ: +1
Call holders
6
QoQ: +1
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-3.30
EPS YoY
—
Revenue (TTM)
$0.6B
Revenue YoY
+36.3%
Net margin
-34.3%
ROE
-28.2%
Debt ratio
24.9%
FCF (TTM)
-$18M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.